Gemcitabine alone or plus cisplatin for biliary tract cancer?

被引：0
|
作者：
Werner Scheithauer
机构：
[1] Medical University of Vienna,Department of Internal Medicine and Cancer Center
来源：
Nature Reviews Clinical Oncology | 2010年 / 7卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A randomized phase III trial that assessed treatment with cisplatin plus gemcitabine or gemcitabine alone for patients with advanced biliary tract cancer has provided evidence for a new standard treatment option for these patients. The therapeutic outcome (that is, overall survival, disease-free survival, and disease control rate), was significantly better in the combination arm with no increase in toxic effects.
引用
收藏
页码：554 / 555
页数：1
相关论文
共 50 条
  • [1] Gemcitabine alone or plus cisplatin for biliary tract cancer?
    Scheithauer, Werner
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (10) : 554 - 555
  • [2] Cisplatin plus Gemcitabine for Biliary Tract Cancer
    Cariati, Andrea
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (02): : 192 - 192
  • [3] Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer
    Weigt, Jochen
    Malfertheiner, Peter
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (04) : 394 - 396
  • [4] Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
    Valle, Juan
    Wasan, Harpreet
    Palmer, Daniel H.
    Cunningham, David
    Anthoney, Alan
    Maraveyas, Anthony
    Madhusudan, Srinivasan
    Iveson, Tim
    Hughes, Sharon
    Pereira, Stephen P.
    Roughton, Michael
    Bridgewater, John
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (14): : 1273 - 1281
  • [5] Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract Cancer
    Park, Jin Myung
    Ryu, Ji Kon
    Paik, Woo Hyun
    Song, Byeong Jun
    Park, Joo Kyung
    Kim, Yong-Tae
    Yoon, Yong Bum
    GASTROENTEROLOGY, 2013, 144 (05) : S529 - S529
  • [6] Evaluation of chemotherapy with cisplatin plus gemcitabine after failure of gemcitabine alone for unresectable or recurrent biliary tract cancer.
    Kameda, Ryo
    Ando, Tomoko
    Kobayashi, Satoshi
    Ueno, Makoto
    Ohkawa, Shinichi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] COST-EFFECTIVENESS OF GEMCITABINE PLUS CISPLATIN VERSUS GEMCITABINE ALONE FOR TREATMENT OF ADVANCED BILIARY TRACT CANCER IN JAPAN
    Arakawa, I
    Uemura, S.
    Murasawa, H.
    Inoue, T.
    VALUE IN HEALTH, 2013, 16 (07) : A416 - A416
  • [8] Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review
    Park, Joon Oh
    Oh, Do-Youn
    Hsu, Chiun
    Chen, Jen-Shi
    Chen, Li-Tzong
    Orlando, Mauro
    Kim, Jong Seok
    Lim, Ho Yeong
    CANCER RESEARCH AND TREATMENT, 2015, 47 (03): : 343 - 361
  • [9] 3.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
    Randall Brand
    中国肿瘤临床, 2010, 37 (12) : 726 - 726
  • [10] A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan
    Tsukiyama I.
    Ejiri M.
    Yamamoto Y.
    Nakao H.
    Yoneda M.
    Matsuura K.
    Arakawa I.
    Saito H.
    Inoue T.
    Journal of Gastrointestinal Cancer, 2017, 48 (4) : 326 - 332
12345